男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

芳香酶(ARO)多克隆抗體

Polyclonal Antibody to Aromatase (ARO)

CYP19A1; CYPXIX; ARO; ARO1; CPV1; CYAR; CYP19; P450AROM; P450-AROM; Estrogen synthase; Cytochrome P450,Family 19,Subfamily A,Polypeptide 1

  • 芳香酶(ARO)多克隆抗體產(chǎn)品包裝(模擬)
  • 芳香酶(ARO)多克隆抗體產(chǎn)品包裝(模擬)
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)ARO的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ARO。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào)適用物種:Mus musculus (Mouse,小鼠)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPC319Mu01芳香酶(ARO)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC319Mu01芳香酶(ARO)多克隆抗體WB; IHC; ICC; IP.

參考文獻(xiàn)

雜志參考文獻(xiàn)
NeuroendocrinologyNeonatal Testosterone Exposure Protects Adult Male Rats from Stroke[Karger: 343804]
Iosr Journal Of PharmacyEffects of Pomegranate Seed Oil and Tamoxifen on Mastectomy Breast Cancer Women[Iosrphr: Source]
PLoS One. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.[Pubmed:25310221]
Gastroenterology ResearchIncreased Expression of Pyloric ERβ Is Associated With Diabetic Gastroparesis in Streptozotocin-Induced Male Diabetic Rats[Gastrores:701]
The Journal of Steroid Biochemistry and Molecular BiologyModifications of Western-type diet regarding protein, fat and sucrose levels as modulators of steroid metabolism and activity in liver[pubmed:27471150]
bioorganic chemistry2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study[Pubmed: 32247112]
Curr OncolPlasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer[Pubmed:35323344]